Takasago, Japan

Toshihiro Takeda

This inventor holds 10 USPTO granted patents and 3 EPO patents. Top assignees: Kaneka Corporation, H. Lundbeck A/s. Active years: 2004-2019.


% Patents Active = 20.0

 

Average Co-Inventor Count = 3.9

ph-index = 2

Forward Citations = 5(Granted Patents)


Location History:

  • Hyogo, JP (2004 - 2006)
  • Takasago, JP (2006 - 2019)

Company Filing History:


Years Active: 2004-2019

Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents

Title: Toshihiro Takeda: Innovator in Pharmaceutical Chemistry

Introduction

Toshihiro Takeda is a prominent inventor based in Takasago, Japan. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 10 patents. His work focuses on innovative methods for producing important chemical compounds used in various pharmaceutical applications.

Latest Patents

One of his latest patents is a method for producing tri-carbobenzoxy-arginine. This process involves carbobenzoxylating arginine or its derivatives by adding carbobenzoxy chloride and a base in a water/organic solvent bilayer system. Another notable patent is for the production of aralkyloxypyrrolidine derivatives. This invention provides a process for converting N-protected-3-hydroxypyrrolidine into a high-purity 3-aralkyloxypyrrolidine derivative, which is crucial for pharmaceutical production.

Career Highlights

Toshihiro Takeda has worked with notable companies such as Kaneka Corporation and H. Lundbeck A/S. His experience in these organizations has allowed him to develop and refine his innovative techniques in chemical production.

Collaborations

Throughout his career, Takeda has collaborated with esteemed colleagues, including Yasuyoshi Ueda and Narumi Kishimoto. These partnerships have contributed to the advancement of his research and the successful development of his patented methods.

Conclusion

Toshihiro Takeda's contributions to pharmaceutical chemistry through his innovative patents and collaborations highlight his importance in the field. His work continues to influence the production of essential pharmaceutical compounds.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…